Brian Calimlim

2.2k total citations · 2 hit papers
70 papers, 1.4k citations indexed

About

Brian Calimlim is a scholar working on Dermatology, Immunology and Allergy and Physiology. According to data from OpenAlex, Brian Calimlim has authored 70 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 57 papers in Dermatology, 35 papers in Immunology and Allergy and 23 papers in Physiology. Recurrent topics in Brian Calimlim's work include Dermatology and Skin Diseases (54 papers), Allergic Rhinitis and Sensitization (29 papers) and Asthma and respiratory diseases (22 papers). Brian Calimlim is often cited by papers focused on Dermatology and Skin Diseases (54 papers), Allergic Rhinitis and Sensitization (29 papers) and Asthma and respiratory diseases (22 papers). Brian Calimlim collaborates with scholars based in United States, Canada and Germany. Brian Calimlim's co-authors include Henrique D. Teixeira, Bonnie B. Dean, Kim Papp, Xiaofei Hu, Emma Guttman‐Yassky, Eric L. Simpson, John Liu, Alvina D. Chu, Norito Katoh and Allan R. Tenorio and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Brian Calimlim

61 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Once-daily upadacitinib versus placebo in adolescents and adults with moderate-to-severe atopic dermatitis (Measure Up 1 and Measure Up 2): results from two replicate double-blind, randomised controlled phase 3 trials

2021 350 citations Emma Guttman‐Yassky, Henrique D. Teixeira et al. profile →
Efficacy and Safety of Upadacitinib in Patients With Moderate to Severe Atopic Dermatitis

2022 122 citations Eric L. Simpson, Kim Papp et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Brian Calimlim United States	19	813	485	318	228	173	70	1.4k
T. Michelle Brown United States	17	182 0.2×	126 0.3×	84 0.3×	84 0.4×	69 0.4×	46	862
Åsa Hellqvist Sweden	18	153 0.2×	315 0.6×	971 3.1×	61 0.3×	260 1.5×	29	1.7k
Richard Shames United States	12	176 0.2×	75 0.2×	348 1.1×	53 0.2×	77 0.4×	20	911
Zarqa Ali Denmark	15	151 0.2×	86 0.2×	307 1.0×	19 0.1×	147 0.8×	51	790
Liza Takiya United States	15	137 0.2×	89 0.2×	45 0.1×	267 1.2×	26 0.2×	47	888
T. Li United States	9	227 0.3×	53 0.1×	127 0.4×	76 0.3×	21 0.1×	15	746
Marisol E. Otero Netherlands	18	277 0.3×	42 0.1×	83 0.3×	104 0.5×	67 0.4×	25	821
Kelly Hollis United States	17	47 0.1×	88 0.2×	114 0.4×	269 1.2×	188 1.1×	39	976
Hidetoshi Mezawa Japan	15	73 0.1×	188 0.4×	200 0.6×	20 0.1×	119 0.7×	49	898
Na Hyun Kim South Korea	18	60 0.1×	160 0.3×	187 0.6×	24 0.1×	185 1.1×	82	996

Countries citing papers authored by Brian Calimlim

Since Specialization

Citations

This map shows the geographic impact of Brian Calimlim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian Calimlim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian Calimlim more than expected).

Fields of papers citing papers by Brian Calimlim

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brian Calimlim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian Calimlim. The network helps show where Brian Calimlim may publish in the future.

Co-authorship network of co-authors of Brian Calimlim

This figure shows the co-authorship network connecting the top 25 collaborators of Brian Calimlim. A scholar is included among the top collaborators of Brian Calimlim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brian Calimlim. Brian Calimlim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Simpson, Eric L., Jonathan I. Silverberg, Vimal H. Prajapati, et al.. (2025). Rapid Itch Improvement and Skin Clearance with Upadacitinib Versus Placebo (Measure Up 1 and Measure Up 2) and Versus Dupilumab (Heads Up): Results from Three Phase 3 Clinical Trials in Patients with Moderate-to-Severe Atopic Dermatitis. Dermatology and Therapy. 15(8). 2061–2076. 1 indexed citations

Silverberg, Jonathan I., Melinda Gooderham, Amy S. Paller, et al.. (2024). Early and Sustained Improvements in Symptoms and Quality of Life with Upadacitinib in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: 52-Week Results from Two Phase III Randomized Clinical Trials (Measure Up 1 and Measure Up 2). American Journal of Clinical Dermatology. 25(3). 485–496. 18 indexed citations

Simpson, Eric L., Vimal H. Prajapati, Yael A. Leshem, et al.. (2024). Upadacitinib Rapidly Improves Patient-Reported Outcomes in Atopic Dermatitis: 16-Week Results from Phase 3 Clinical Trials (Measure Up 1 and 2). Dermatology and Therapy. 14(5). 1127–1144. 3 indexed citations

Kwatra, Shawn G., Marjolein de Bruin‐Weller, Jonathan I. Silverberg, et al.. (2024). Targeted Combined Endpoint Improvement in Patient and Disease Domains in Atopic Dermatitis: A Treat-to-Target Analysis of Adults with Moderate-to-Severe Atopic Dermatitis Treated with Upadacitinib. Acta Dermato Venereologica. 104. adv18452–adv18452. 1 indexed citations

Reich, Kristian, Marjolein de Bruin‐Weller, Mette Deleuran, et al.. (2023). Higher levels of response on clinical atopic dermatitis severity measures are associated with meaningful improvements in patient‐reported symptom and quality of life measures: Integrated analysis of three Upadacitinib phase 3 trials. Journal of the European Academy of Dermatology and Venereology. 37(8). 1634–1641. 8 indexed citations

Eyerich, Kilian, Melinda Gooderham, Stephen Shumack, et al.. (2023). Real‐world clinical, psychosocial and economic burden of atopic dermatitis: Results from a multicountry study. Journal of the European Academy of Dermatology and Venereology. 38(2). 340–353. 26 indexed citations

Kwatra, Shawn G., Peter Lio, Stephan Weidinger, et al.. (2023). Patient preferences for atopic dermatitis treatments: a discrete choice experiment. Journal of Dermatological Treatment. 34(1). 2222201–2222201. 11 indexed citations

Guttman‐Yassky, Emma, Jonathan I. Silverberg, Diamant Thaçi, et al.. (2023). Upadacitinib treatment withdrawal and retreatment in patients with moderate‐to‐severe atopic dermatitis: Results from a phase 2b, randomized, controlled trial. Journal of the European Academy of Dermatology and Venereology. 37(12). 2558–2568. 12 indexed citations

Meadows, Keith, Brian Calimlim, Sandra Goss, et al.. (2023). A Patient-Centred Conceptual Model of Nocturnal Scratch and its Impact in Atopic Dermatitis: A Mixed-Methods Study Supporting the Development of Novel Digital Measurements. SHILAP Revista de lepidopterología. 3(5). 4 indexed citations

10.

Thyssen, Jacob P., Diamant Thaçi, Thomas Bieber, et al.. (2023). Upadacitinib for moderate‐to‐severe atopic dermatitis: Stratified analysis from three randomized phase 3 trials by key baseline characteristics. Journal of the European Academy of Dermatology and Venereology. 37(9). 1871–1880. 11 indexed citations

11.

Silverberg, Jonathan I., Yael A. Leshem, Brian Calimlim, Jeffrey G. McDonald, & Leighann Litcher‐Kelly. (2023). Psychometric evaluation of the Worst Pruritus Numerical Rating Scale (NRS), Atopic Dermatitis Symptom Scale (ADerm-SS), and Atopic Dermatitis Impact Scale (ADerm-IS). Current Medical Research and Opinion. 39(10). 1289–1296. 1 indexed citations

12.

Silverberg, Jonathan I., Marjolein de Bruin‐Weller, Brian Calimlim, et al.. (2023). Aggregate Response Benefit in Skin Clearance and Itch Reduction with Upadacitinib or Dupilumab in Patients with Moderate-to-Severe Atopic Dermatitis®. Dermatitis. 35(3). 266–274. 1 indexed citations

13.

Silverberg, Jonathan I., Brenda Simpson, Katrina Abuabara, et al.. (2023). Prevalence and burden of atopic dermatitis involving the head, neck, face, and hand: A cross sectional study from the TARGET-DERM AD cohort. Journal of the American Academy of Dermatology. 89(3). 519–528. 18 indexed citations

14.

Blauvelt, Andrew, Barry Ladizinski, Vimal H. Prajapati, et al.. (2023). Efficacy and safety of switching from dupilumab to upadacitinib versus continuous upadacitinib in moderate-to-severe atopic dermatitis: Results from an open-label extension of the phase 3, randomized, controlled trial (Heads Up). Journal of the American Academy of Dermatology. 89(3). 478–485. 23 indexed citations

15.

Silverberg, Jonathan I., Hwanhee Hong, Jacob P. Thyssen, et al.. (2022). Comparative Efficacy of Targeted Systemic Therapies for Moderate to Severe Atopic Dermatitis without Topical Corticosteroids: Systematic Review and Network Meta-analysis. Dermatology and Therapy. 12(5). 1181–1196. 39 indexed citations

16.

Walshaw, Patricia D., L. Gyulai, Michael Bauer, et al.. (2018). Adjunctive thyroid hormone treatment in rapid cycling bipolar disorder: A double‐blind placebo‐controlled trial of levothyroxine (L‐T₄) and triiodothyronine (T₃). Bipolar Disorders. 20(7). 594–603. 36 indexed citations

17.

Eliasson, Lina, et al.. (2017). Patients’ Preferences for the Treatment of Metastatic Castrate-resistant Prostate Cancer: A Discrete Choice Experiment. Clinical Therapeutics. 39(4). 723–737. 39 indexed citations

18.

Massey, Philip M., et al.. (2012). Contextualizing an expanded definition of health literacy among adolescents in the health care setting. Health Education Research. 27(6). 961–974. 51 indexed citations

19.

Dean, Bonnie B., et al.. (2009). The Impact of Uncontrolled Asthma on Absenteeism and Health-Related Quality of Life. Journal of Asthma. 46(9). 861–866. 118 indexed citations

20.

Dean, Bonnie B., Daniel Aguilar, Lawrence F. Johnson, et al.. (2009). The Relationship Between the Prevalence of Nighttime Gastroesophageal Reflux Disease and Disease Severity. Digestive Diseases and Sciences. 55(4). 952–959. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact